Journal of clinical oncology ; JCO ; official journal of the American Society of Clinical Oncology

Format: Elektronische Zeitschrift
Sprache: Englisch
veröffentlicht: Alexandria, Va.: American Society of Clinical Oncology, 1983-,
Baltimore, Md. [u.a.]: Lippincott Williams & Wilkins, anfangs
Schlagworte:
RVK-Klassifikation: 44.81Ähnliche Treffer finden
ISSN: 1527-7755
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Einzelbände

Band Jahr Titel
30(2012), 17, Seite 2070-2078 June 10, 2012 Sunitinib plus Erlotinib versus placebo plus Erlotinib in patients with previously treated advanced non-small-cell lung cancer a phase III trial Giorgio V. Scagliotti, Maciej Krzakowski, Aleksandra Szczesna, Janos Strausz, Anatoly Makhson, Martin Reck, Rafal F. Wierzbicki, Istvan Albert, Michael Thomas, Jose Elias Abrao Miziara, Zsolt S. Papai, Nina Karaseva, Sumitra Thongprasert, Elsa Dalmau Portulas, Joachim von Pawel, Ke Zhang, Paulina Selaru, Lesley Tye, Richard C. Chao, Ramaswamy Govindan
30(2012), 35, Seite 4323-4329 2012 Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P. Radich, Giuseppe Saglio, Andreas Hochhaus, Timothy P. Hughes, and Martin C. Müller
32(2014), 5, Seite 415-423 2014 Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib results from the randomized CML-study IV Hehlmann, Rüdiger; Müller, Martin C.; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schreiber, Annette; Proetel, Ulrike; Pletsch, Nadine; Pfirrmann, Markus; Haferlach, Claudia; Schnittger, Susanne; Einsele, Hermann; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Bärlocher, Gabriela M.; Ehninger, Gerhard; Heim, Dominik; Heimpel, Hermann; Nerl, Christoph; Krause, Stefan W.; Hossfeld, Dieter K.; Kolb, Hans-Jochem; Hasford, Jörg; Saussele, Susanne; Hochhaus, Andreas
32(2014), 9, Seite 886-896 March 20, 2014 Cytogenetic prognostication within medulloblastoma subgroups David J.H. Shih, Paul A. Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Xin Wang, Adrian M. Dubuc, Livia Garzia, John Peacock, Stephen C. Mack, Xiaochong Wu, Adi Rolider, A. Sorana Morrissy, Florence M.G. Cavalli, David T.W. Jones, Karel Zitterbart, Claudia C. Faria, Ulrich Schüller, Leos Kren, Toshihiro Kumabe, Teiji Tominaga, Young Shin Ra, Miklós Garami, Peter Hauser, Jennifer A. Chan, Shenandoah Robinson, László Bognár, Almos Klekner, Ali G. Saad, Linda M. Liau, Steffen Albrecht, Adam Fontebasso, Giuseppe Cinalli, Pasqualino De Antonellis, Massimo Zollo, Michael K. Cooper, Reid C. Thompson, Simon Bailey, Janet C. Lindsey, Concezio Di Rocco, Luca Massimi, Erna M.C. Michiels, Stephen W. Scherer, Joanna J. Phillips, Nalin Gupta, Xing Fan, Karin M. Muraszko, Rajeev Vibhakar, Charles G. Eberhart, Maryam Fouladi, Boleslaw Lach, Shin Jung, Robert J. Wechsler-Reya, Michelle Fèvre-Montange, Anne Jouvet, Nada Jabado, Ian F. Pollack, William A. Weiss, Ji-Yeoun Lee, Byung-Kyu Cho, Seung-Ki Kim, Kyu-Chang Wang, Jeffrey R. Leonard, Joshua B. Rubin, Carmen de Torres, Cinzia Lavarino, Jaume Mora, Yoon-Jae Cho, Uri Tabori, James M. Olson, Amar Gajjar, Roger J. Packer, Stefan Rutkowski, Scott L. Pomeroy, Pim J. French, Nanne K. Kloosterhof, Johan M. Kros, Erwin G. Van Meir, Steven C. Clifford, Franck Bourdeaut, Olivier Delattre, François F. Doz, Cynthia E. Hawkins, David Malkin, Wieslawa A. Grajkowska, Marta Perek-Polnik, Eric Bouffet, James T. Rutka, Stefan M. Pfister and Michael D. Taylor
32(2014), 20, Seite 2173-2183 10 July 2014 Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression–Related Death Philippe Moreau, Michele Cavo, Pieter Sonneveld, Laura Rosinol, Michel Attal, Annalisa Pezzi, Hartmut Goldschmidt, Juan Jose Lahuerta, Gerald Marit, Antonio Palumbo, Bronno van der Holt, Joan Bladé, Maria Teresa Petrucci, Kai Neben, Jesus san Miguel, Francesca Patriarca, Henk Lokhorst, Elena Zamagni, Cyrille Hulin, Norma Gutierrez, Thierry Facon, Denis Caillot, Lotfi Benboubker, Jean-Luc Harousseau, Xavier Leleu, Herve ́ Avet-Loiseau, and Jean-Yves Mary
32(2014), 29, Seite 3212-3222 8 September 2014 PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert
32(2014), 30, Seite 3413-3420 October 20 2014 Aprepitant, Granisetron, and Dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose Melphalan in autologous transplantation for multiple myeloma results of a randomized, placebo-controlled phase III trial Thomas Schmitt, Hartmut Goldschmidt, Kai Neben, Anja Freiberger, Johannes Hüsing, Martina Gronkowski, Markus Thalheimer, Le Hang Pelzl, Gerd Mikus, Jürgen Burhenne, Anthony D. Ho, and Gerlinde Egerer
32(2014), 31, Seite 3540-3553 2014 Four-week prevalence of mental disorders in patients with cancer across major tumor entities Anja Mehnert, Elmar Brähler, Hermann Faller, Martin Härter, Monika Keller, Holger Schulz, Karl Wegscheider, Joachim Weis, Anna Boehncke, Bianca Hund, Katrin Reuter, Matthias Richard, Susanne Sehner, Sabine Sommerfeldt, Carina Szalai, Hans-Ulrich Wittchen and Uwe Koch
32(2014), 35, Seite 4012-4019 2014 Randomized phase III trial of Amrubicin versus Topotecan as second-line treatment for patients with small-cell lung cancer Joachim von Pawel, Robert Jotte, David R. Spigel, Mary E. R. O'Brien, Mark A. Socinski, Jörg Mezger, Martin Steins, Léon Bosquée, Jeffrey Bubis, Kristiaan Nackaerts, José M. Trigo, Philip Clingan, Wolfgang Schütte, Paul Lorigan, Martin Reck, Manuel Domine, Frances A. Shepherd, Shaoyi Li, Markus F. Renschler
32(2014), 36, Seite 4127-4133 2014 Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.
32(2014), Seite 2109-2111 2014 Sketching the Human Experience
33(2015), 19, Seite 2166-2175 July 2015 Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma Martin J.B. Taphoorn, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren P. Mason, Frank Saran, Ryo Nishikawa, Magalie Hilton, Christina Theodore-Oklota, Arliene Ravelo, Olivier L. Chinot
33(2015), 25, Seite 2735-2746 1 September 2015 Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide retrospective analysis of the AVAglio trial Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais
33(2015), 25, Seite 2823-2825 1 September 2015 Basket trials just the end of the first quarter Albrecht Stenzinger, Wilko Weichert, Jochen K. Lennerz, Frederick Klauschen
33(2015), 25, Seite 2828-2828 1 September 2015 Reply to J. Dekker et al Anja Mehnert, Elmar Brähler, Hermann Faller, Martin Härter, Monika Keller, Holger Schulz, Karl Wegscheider, Joachim Weis, Hans-Ulrich Wittchen, Uwe Koch
33(2015), 26, Seite 2863-2869 10 September 2015 Revised international staging system for multiple myeloma a report from international myeloma working group Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, Henk M. Lokhorst, Hartmut Goldschmidt, Laura Rosinol, Paul Richardson, Simona Caltagirone, Juan José Lahuerta, Thierry Facon, Sara Bringhen, Francesca Gay, Michel Attal, Roberto Passera, Andrew Spencer, Massimo Offidani, Shaji Kumar, Pellegrino Musto, Sagar Lonial, Maria T. Petrucci, Robert Z. Orlowski, Elena Zamagni, Gareth Morgan, Meletios A. Dimopoulos, Brian G.M. Durie, Kenneth C. Anderson, Pieter Sonneveld, Jésus San Miguel, Michele Cavo, S. Vincent Rajkumar, and Philippe Moreau
33(2015), 34, Seite 4077-4084 26 October 2015 Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma final analysis of a randomized phase III dermatologic cooperative oncology group trial Peter Mohr, Axel Hauschild, Uwe Trefzer, Alexander Enk, Wolfgang Tilgen, Carmen Loquai, Helen Gogas, Thomas Haalck, Josef Koller, Reinhard Dummer, Ralf Gutzmer, Norbert Brockmeyer, Erhard Hölzle, Cord Sunderkötter, Cornelia Mauch, Annette Stein, Lars A. Schneider, Maurizio Podda, Daniela Göppner, Dirk Schadendorf, and Michael Weichenthal
34(2016), 23, Seite 2750-2760 June 16, 2016 Age- and tumor subtype-specific breast cancer risk estimates for CHEK2*1100delC carriers Marjanka K. Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, Muriel A. Adank, Hanne Meijers, Quinten Waisfisz, Antoinette Hollestelle, Mieke Schutte, Ans van den Ouweland, Maartje Hooning, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Antonis C. Antoniou, Volker Arndt, Marina Bermisheva, Natalia V. Bogdanova, Manjeet K. Bolla, Hiltrud Brauch, Hermann Brenner, Thomas Brüning, Barbara Burwinkel, Jenny Chang-Claude, Georgia Chenevix-Trench, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Alison M. Dunning, Peter A. Fasching, Jonine Figueroa, Olivia Fletcher, Henrik Flyger, Eva Galle, Montserrat García-Closas, Graham G. Giles, Lothar Haeberle, Per Hall, Peter Hillemanns, John L. Hopper, Anna Jakubowska, Esther M. John, Michael Jones, Elza Khusnutdinova, Julia A. Knight, Veli-Matti Kosma, Vessela Kristensen, Andrew Lee, Annika Lindblom, Jan Lubinski, Arto Mannermaa, Sara Margolin, Alfons Meindl, Roger L. Milne, Taru A. Muranen, Polly A. Newcomb, Kenneth Offit, Tjoung-Won Park-Simon, Julian Peto, Paul D.P. Pharoah, Mark Robson, Anja Rudolph, Elinor J. Sawyer, Rita K. Schmutzler, Caroline Seynaeve, Julie Soens, Melissa C. Southey, Amanda B. Spurdle, Harald Surowy, Anthony Swerdlow, Rob A.E.M. Tollenaar, Ian Tomlinson, Amy Trentham-Dietz, Celine Vachon, Qin Wang, Alice S. Whittemore, Argyrios Ziogas, Lizet van der Kolk, Heli Nevanlinna, Thilo Dörk, Stig Bojesen and Douglas F. Easton
35(2017), 13, Seite 1444-1450 February 27, 2017 Late relapse of classical Hodgkin lymphoma an analysis of the German Hodgkin Study Group HD7 to HD12 trials Paul J. Bröckelmann, Helen Goergen, Charlotte Kohnhorst, Bastian von Tresckow, Alden Moccia, Jana Markova, Julia Meissner, Andrea Kerkhoff, Wolf-Dieter Ludwig, Michael Fuchs, Peter Borchmann, and Andreas Engert
35(2017), 28, Seite 3240-3261 2017 Antiemetics American Society of Clinical Oncology Clinical Practice guideline update Paul J. Hesketh, Mark G. Kris, Ethan Basch, Kari Bohlke, Sally Y. Barbour, Rebecca Anne Clark-Snow, Michael A. Danso, Kristopher Dennis, L. Lee Dupuis, Stacie B. Dusetzina, Cathy Eng, Petra C. Feyer, Karin Jordan, Kimberly Noonan, Dee Sparacio, Mark R. Somerfield, and Gary H. Lyman